J Bacteriol Virol.  2012 Jun;42(2):177-179. 10.4167/jbv.2012.42.2.177.

Silver Nanoparticles as a Smart Antimicrobial Agent

• Yang EJ
• Jang J
• Kim S
• Choi IH

• KMID: 1717690
• DOI: http://doi.org/10.4167/jbv.2012.42.2.177

Abstract

In modern medicine the resistance to conventional antibiotics is becoming a serious concern due to high instances of mortality. Several metallic nanoparticles are suggested as promising anti-microbial agents against multidrug-resistant bacteria and some viruses. Among the nanoparticles mentioned, we review the recent finding which demonstrate the impact of silver nanoparticles on antimicrobial activities and recommend them as a potential candidate for restraining infections.

Keyword

Silver nanoparticles; Antimicrobial agent

MeSH Terms

Anti-Bacterial Agents
Anti-Infective Agents
Bacteria
History, Modern 1601-
Metal Nanoparticles
Nanoparticles
Silver
Anti-Bacterial Agents
Anti-Infective Agents
Silver

Reference

1. Mainous AG 3rd, Diaz VA, Matheson EM, Gregorie SH, Hueston WJ. Trends in hospitalizations with antibiotic-resistant infections: U.S., 1997-2006. Public Health Rep. 2011. 126:354–360.

2. Westh H, Zinn CS, Rosdahl VT. An international multicenter study of antimicrobial consumption and resistance in Staphylococcus aureus isolates from 15 hospitals in 14 countries. Microb Drug Resist. 2004. 10:169–176.

3. Alexander JW. History of the medical use of asilver. Surg Infect (Larchmt). 2009. 10:289–292.

4. Amato E, Diaz-Fernandez YA, Taglietti A, Pallavicini P, Pasotti L, Cucca L, et al. Synthesis, characterization and antibacterial activity against Gram positive and Gram negative bacteria of biomimetically coated silver nanoparticles. Langmuir. 2011. 27:9165–9173.

5. Brandt O, Mildner M, Egger AE, Groessl M, Rix U, Posch M, et al. Nanoscalic silver possesses broad-spectrum antimicrobial activities and exhibits fewer toxicological side effects than silver sulfadiazine. Nanomedicine. 2012. 8:478–488.

6. Guzman M, Dille J, Godet S. Synthesis and antibacterial activity of silver nanoparticles against gram-positive and gram-negative bacteria. Nanomedicine. 2012. 8:37–45.

7. Kim SW, Baek YW, An YJ. Assay-dependent effect of silver nanoparticles to Escherichia coli and Bacillus subtilis. Appl Microbiol Biotechnol. 2011. 92:1045–1052.

8. Kim JS, Kuk E, Yu KN, Kim JH, Park SJ, Lee HJ, et al. Antimicrobial effects of silver nanoparticles. Nanomedicine. 2007. 3:95–101.

9. Sintubin L, De Gusseme B, Van der Meeren P, Pycke BF, Verstraete W, Boon N. The antibacterial activity of biogenic silver and its mode of action. Appl Microbiol Biotechnol. 2011. 91:153–162.

10. Sharma VK, Yngard RA, Lin Y. Silver nanoparticles: green synthesis and their antimicrobial activities. Adv Colloid Interface Sci. 2009. 145:83–96.

11. Park J, Lim DH, Lim HJ, Kwon T, Choi JS, Jeong S, et al. Size dependent macrophage responses and toxicological effects of Ag nanoparticles. Chem Commun (Camb). 2011. 47:4382–4384.

12. Li WR, Xie XB, Shi QS, Duan SS, Ouyang YS, Chen YB. Antibacterial effect of silver nanoparticles on Staphylococcus aureus. Biometals. 2011. 24:135–141.

13. Hermans MH. Silver-containing dressings and the need for evidence. Adv Skin Wound Care. 2007. 20:166–173.

14. Toy LW, Macera L. Evidence-based review of silver dressing use on chronic wounds. J Am Acad Nurse Pract. 2011. 23:183–192.

15. Percival SL, Thomas J, Linton S, Okel T, Corum L, Slone W. The antimicrobial efficacy of silver on antibiotic-resistant bacteria isolated from burn wounds. Int Wound J. 2011.

16. Guthrie KM, Agarwal A, Tackes DS, Johnson KW, Abbott NL, Murphy CJ, et al. Antibacterial efficacy of silver-Impregnated polyelectrolyte multilayers immobilized on a biological dressing in a murine Wound Infection Model. Ann Surg. 2012.

17. Li D, Diao J, Zhang J, Liu J. Fabrication of new chitosan-based composite sponge containing silver nanoparticles and its antibacterial properties for wound dressing. J Nanosci Nanotechnol. 2011. 11:4733–4738.

18. Marie Arockianathan P, Sekar S, Kumaran B, Sastry TP. Preparation, characterization and evaluation of biocomposite films containing chitosan and sago starch impregnated with silver nanoparticles. Int J Biol Macromol. 2012. 50:939–946.

19. Kang K, Lim DH, Choi IH, Kang T, Lee K, Moon EY, et al. Vascular tube formation and angiogenesis induced by polyvinylpyrrolidone-coated silver nanoparticles. Toxicol Lett. 2011. 205:227–234.

20. Chen M, Yang Z, Wu H, Pan X, Xie X, Wu C. Antimicrobial activity and the mechanism of silver nanoparticle thermosensitive gel. Int J Nanomedicine. 2011. 6:2873–2877.

21. Ebert M, Assadian O, Hubner NO, Koburger T, Kramer A. Antimicrobial efficacy of the silver wound dressing Biatain Ag in a disc carrier test simulating wound secretion. Skin Pharmacol Physiol. 2011. 24:337–341.

22. Lara HH, Ixtepan-Turrent L, Garza Trevino EN, Singh DK. Use of silver nanoparticles increased inhibition of cell-associated HIV-1 infection by neutralizing antibodies developed against HIV-1 envelope proteins. J Nanobiotechnology. 2011. 9:38.

23. Lu L, Sun RW, Chen R, Hui CK, Ho CM, Luk JM, et al. Silver nanoparticles inhibit hepatitis B virus replication. Antivir Ther. 2008. 13:253–262.

24. Xiang DX, Chen Q, Pang L, Zheng CL. Inhibitory effects of silver nanoparticles on H1N1 influenza A virus in vitro. J Virol Methods. 2011. 178:137–142.

25. Speshock JL, Murdock RC, Braydich-Stolle LK, Schrand AM, Hussain SM. Interaction of silver nanoparticles with Tacaribe virus. J Nanobiotechnology. 2010. 8:19.